Found 2 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
C-X-C chemokine receptor type 3
(Homo sapiens (Human)) | BDBM166478
(US9073853, 37)Show SMILES COc1cc(CN(C[C@H]2CC[C@@H](CC2)C(O)=O)[C@@H](C)c2ccc(Cl)cc2)ccc1OCCn1c(=O)ccn(C)c1=O |r,wU:17.18,8.7,wD:11.14,(4.67,-2.54,;3.33,-3.31,;2,-2.54,;.67,-3.31,;-.67,-2.54,;-2,-3.31,;-3.33,-2.54,;-3.33,-1,;-2.25,.09,;-2.64,1.58,;-1.55,2.67,;-.07,2.27,;.33,.78,;-.76,-.31,;1.02,3.36,;.62,4.85,;2.51,2.96,;-4.67,-3.31,;-4.67,-4.85,;-6,-2.54,;-6,-1,;-7.34,-.23,;-8.67,-1,;-10,-.23,;-8.67,-2.54,;-7.34,-3.31,;-.67,-1,;.67,-.23,;2,-1,;3.33,-.23,;4.67,-1,;6,-.23,;7.34,-1,;8.67,-.23,;8.67,1.31,;10,-1,;10,-2.54,;8.67,-3.31,;8.67,-4.85,;7.34,-2.54,;6,-3.31,)| Show InChI InChI=1S/C31H38ClN3O6/c1-21(24-9-11-26(32)12-10-24)34(19-22-4-7-25(8-5-22)30(37)38)20-23-6-13-27(28(18-23)40-3)41-17-16-35-29(36)14-15-33(2)31(35)39/h6,9-15,18,21-22,25H,4-5,7-8,16-17,19-20H2,1-3H3,(H,37,38)/t21-,22-,25-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 76 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Co. Ltd
Curated by ChEMBL
| Assay Description Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting method |
Bioorg Med Chem Lett 26: 5418-5428 (2016)
Article DOI: 10.1016/j.bmcl.2016.10.035 BindingDB Entry DOI: 10.7270/Q28S4RW9 |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 3
(Homo sapiens (Human)) | BDBM166478
(US9073853, 37)Show SMILES COc1cc(CN(C[C@H]2CC[C@@H](CC2)C(O)=O)[C@@H](C)c2ccc(Cl)cc2)ccc1OCCn1c(=O)ccn(C)c1=O |r,wU:17.18,8.7,wD:11.14,(4.67,-2.54,;3.33,-3.31,;2,-2.54,;.67,-3.31,;-.67,-2.54,;-2,-3.31,;-3.33,-2.54,;-3.33,-1,;-2.25,.09,;-2.64,1.58,;-1.55,2.67,;-.07,2.27,;.33,.78,;-.76,-.31,;1.02,3.36,;.62,4.85,;2.51,2.96,;-4.67,-3.31,;-4.67,-4.85,;-6,-2.54,;-6,-1,;-7.34,-.23,;-8.67,-1,;-10,-.23,;-8.67,-2.54,;-7.34,-3.31,;-.67,-1,;.67,-.23,;2,-1,;3.33,-.23,;4.67,-1,;6,-.23,;7.34,-1,;8.67,-.23,;8.67,1.31,;10,-1,;10,-2.54,;8.67,-3.31,;8.67,-4.85,;7.34,-2.54,;6,-3.31,)| Show InChI InChI=1S/C31H38ClN3O6/c1-21(24-9-11-26(32)12-10-24)34(19-22-4-7-25(8-5-22)30(37)38)20-23-6-13-27(28(18-23)40-3)41-17-16-35-29(36)14-15-33(2)31(35)39/h6,9-15,18,21-22,25H,4-5,7-8,16-17,19-20H2,1-3H3,(H,37,38)/t21-,22-,25-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| US Patent
| n/a | n/a | 76 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI
US Patent
| Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... |
US Patent US9073853 (2015)
BindingDB Entry DOI: 10.7270/Q2Q23Z10 |
More data for this Ligand-Target Pair | |